How many insider trades does FilingIQ track for ENOV?

FilingIQ tracks 260 Form 4 insider transactions for ENOV (Enovis CORP), covering filings from Apr 5, 2022 onwards. 36 of those were filed in the last 90 days.

Are ENOV insiders net buyers or net sellers?

Across the full Form 4 history for ENOV, 13 transactions (5%) were open-market purchases and 38 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ENOV insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ENOV in?

Enovis CORP (ENOV) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.29B.

ENOV insider trading

NYSE Healthcare

Enovis CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

260

Last 90 days

Buys / sells

5% / 15%

Market cap

$1.29B

About Enovis CORP

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Company website: www.enovis.com

ENOV insider activity at a glance

FilingIQ has scored 260 insider transactions for ENOV since Apr 5, 2022. The most recent filing in our index is dated May 12, 2026.

Across the full history, 13 open-market purchases and 38 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ENOV insider trades is 56.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ENOV trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ENOV?: FilingIQ tracks 260 Form 4 insider transactions for ENOV (Enovis CORP), covering filings from Apr 5, 2022 onwards. 36 of those were filed in the last 90 days.
Are ENOV insiders net buyers or net sellers?: Across the full Form 4 history for ENOV, 13 transactions (5%) were open-market purchases and 38 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ENOV insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ENOV in?: Enovis CORP (ENOV) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.29B.

Methodology & sources

Every ENOV insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.